Neurotech Solutions

Company Overview

Snapshot

Founded in March 2008, Neurotech Solutions operates with 11–50 employees. The company has secured $3.55M in total capital across three funding rounds from three investors. In March 2018, Neurotech Solutions received funding from Guangzhou Sino-Israel Biotech Investment Fund (GIBF) to support its aggressive growth in the ADHD screening and diagnosis market in China.

Business overview

Neurotech Solutions is a digital health company dedicated to eliminating undiagnosed ADHD and helping individuals with ADHD lead better lives. The company's core technology is a cloud-based, AI-driven online test designed to diagnose ADHD, initially implemented in the MOXO d-CPT clinical product. This decision-support tool provides objective, standardized results on attentional difficulties within minutes. Neurotech Solutions also offers AXON-School, an educational product for K-12 children that identifies attentional difficulties and suggests personalized learning strategies. The company serves healthcare providers, educational institutions, and consumers globally, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support.

Strategic signal

In March 2018, Neurotech Solutions secured significant funding to fuel its aggressive growth strategy for ADHD screening and diagnosis in China. This expansion into a major international market signals strong commercial validation for its AI-based diagnostic technology and indicates a strategic focus on global market penetration, particularly in regions with high demand for digital health solutions.

Company Intelligence Q&A

What is Neurotech Solutions' primary focus?

Neurotech Solutions is a digital health company focused on eliminating undiagnosed ADHD and helping individuals with ADHD improve their lives and fulfill their potential.

What is the core technology behind Neurotech Solutions' products?

The company's core technology is a cloud-based, AI-driven online test that functions like a game, providing objective and standardized results for attentional difficulties.

Which clinical product utilizes Neurotech Solutions' technology?

Neurotech Solutions' technology is implemented in MOXO d-CPT, a clinical product that serves as a decision-support tool for the diagnosis of ADHD.

What is the purpose of AXON-School?

AXON-School is an educational product from Neurotech Solutions intended for K-12 children, designed to objectively highlight attentional difficulties and suggest educational strategies for personalized learning.

When did Neurotech Solutions expand into China?

Neurotech Solutions opened a subsidiary in Guangzhou, China, in 2021, and in March 2018, the company secured funding to support the growth of its ADHD screening and diagnosis business in China.